Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain

Molecular Brain Research

Volumn 66, Issue 1-2, 1999, Pages 184-187

  Wang, Xiao Min ^b   Zhou, Yan ^a   Spangler, Rudolph ^a   Ho, Ann ^a   Han, Ji Shen ^b   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Kappa opioid receptor; Morphine; Preprodynorphin; Preproenkephalin

Indexed keywords

KAPPA OPIATE RECEPTOR; MESSENGER RNA; MORPHINE SULFATE; OPIATE RECEPTOR; PREPRODYNORPHIN; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; LIGAND BINDING; MORPHINE ADDICTION; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN CHEMISTRY; DYNORPHINS; ENKEPHALINS; GENE EXPRESSION; MALE; MORPHINE; NARCOTICS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RNA, MESSENGER;

EID: 0033586358     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00021-2     Document Type: Article

References (28)

1. Altier N., Stewart J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 285:1998;208-215.
2. Branch A.D., Unterwald E.M., Lee S.E., Kreek M.J. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol. Brain Res. 14:1992;231-238.
3. Buzas B., Rosenberger J., Cox B.M. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport. 7:1996;1505-1508.
4. Castelli M.P., Melis M., Mameli M., Fadda P., Diaz G., Gessa G.L. Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Mol. Brain Res. 45:1997;149-153.
5. 1-17 reduces extracellular dopamine levels in the nucleus accumbens. NIDA Res. Monogr. 187:1996;113.
6. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
7. Gudehithlu K.P., Bhargava H.N. Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine. Peptides. 16:1995;415-419.
8. Hurd Y.L., Ungerstedt U. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse. 3:1989;48-54.
9. Kluttz B.W., Vrana K.E., Dworkin S.I., Childers S.R. Effects of morphine on forskolin-stimulated pro-enkephalin mRNA levels in rat striatum: a model for acute and chronic opioid actions in brain. Mol. Brain Res. 32:1995;313-320.
10. Lacey M.G., Mercuri N.B., North R.A. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J. Neurosci. 9:1989;1233-1241.
11. Lightman S.L., Young W.S. III Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature. 328:1987;643-645.
12. Maisonneuve I.M., Kreek M.J. Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 268:1994;916-921.
13. Manzanares J., Lookingland K.J., Moore K.E. Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J. Pharmacol. Exp. Ther. 256:1991;500-505.
14. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
15. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature. 389:1997;382-385.
16. Ren M.F., Lu C.H., Han J.S. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord. Peptides. 6:1985;1015-1020.
17. Schmauss C., Herz A. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. Euro. J. Pharm. 135:1987;429-431.
18. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273:1995;808-815.
19. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
20. Spangler R., Ho A., Zhou Y., Maggos C., Yuferov V., Kreek M.J. Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA. Mol. Brain Res. 38:1996;71-76.
21. Spangler R., Unterwald E.M., Kreek M.J. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19:1993;323-327.
22. Spangler R., Zhou Y., Maggos C.E., Schlussman S.D., Ho A., Kreek M.J. Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute 'binge' cocaine. Mol. Brain Res. 44:1996;139-142.
23. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
24. Trujillo K.A., Bronstein D.M., Sanchez I.O., Akil H. Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides. Brain Res. 698:1995;69-78.
25. Tulunay F.C., Jen M.F., Chang J.K., Loh H.H., Lee N.M. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J. Pharmacol. Exp. Ther. 219:1981;296-298.
26. Uhl G.R., Ryan J.P., Schwartz J.P. Morphine alters preproenkephalin gene expression. Brain Res. 459:1988;391-397.
27. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 5:1994;1613-1616.
28. Werling L.L., Frattali A., Portoghese P.S., Takemori A.E., Cox B.M. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exp. Ther. 246:1988;282-286.